Literature DB >> 9586691

Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis.

A Spadaro1, E Taccari, F Sensi, V Riccieri, A Sili Scavalli, A Zoppini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9586691     DOI： 10.1007/BF01450970

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  8 in total

1.  Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters.

Authors:  A Spadaro; E Taccari; V Riccieri; F Sensi; A Sili Scavalli; A Zoppini
Journal:  Clin Exp Rheumatol       Date:  1996 Jul-Aug       Impact factor: 4.473

2.  Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.

Authors:  R P Polisson; M A Dooley; D V Dawson; D S Pisetsky
Journal:  Arthritis Rheum       Date:  1994-01

3.  Low dose cyclosporine A in psoriatic arthritis: relation between soluble interleukin 2 receptors and response to therapy.

Authors:  C Salvarani; P Macchioni; L Boiardi; F Rossi; M Casadei Maldini; R Mancini; E Beltrandi; L Lodi; G Bisighini; I Portioli
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

4.  Effect of cyclosporin A on interleukin-6 and soluble interleukin-2 receptor in patients with rheumatoid arthritis.

Authors:  A Crilly; S Kolta; M Dougados; R D Sturrock; B Amor; H A Capell; R Madhok
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

5.  Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.

Authors:  P Barrera; A M Boerbooms; E M Janssen; R W Sauerwein; H Gallati; J Mulder; T de Boo; P N Demacker; L B van de Putte; J W van der Meer
Journal:  Arthritis Rheum       Date:  1993-08

6.  Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients.

Authors:  I Holt; R G Cooper; S J Hopkins
Journal:  Eur J Clin Invest       Date:  1991-10       Impact factor: 4.686

7.  Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.

Authors:  A Spadaro; V Riccieri; A Sili-Scavalli; F Sensi; E Taccari; A Zoppini
Journal:  Clin Exp Rheumatol       Date:  1995 Sep-Oct       Impact factor: 4.473

8.  Cytokine inter-relationships and their association with disease activity in arthritis.

Authors:  I Holt; R G Cooper; J Denton; A Meager; S J Hopkins
Journal:  Br J Rheumatol       Date:  1992-11
  8 in total
  2 in total

1.  Steps in the management of psoriatic arthritis: a guide for clinicians.

Authors:  Raquel Cuchacovich; Rodolfo Perez-Alamino; Ignacio Garcia-Valladares; Luis R Espinoza
Journal:  Ther Adv Chronic Dis       Date:  2012-11       Impact factor: 5.091

2.  Management of particular clinical situations in psoriatic arthritis: an expert's recommendation document based on systematic literature review and extended Delphi process.

Authors:  Rosario García-Vicuña; Noemí Garrido; Susana Gómez; Beatriz Joven; Rubén Queiro; Julio Ramírez; Francisco Rebollo; Estíbaliz Loza; Agustí Sellas
Journal:  Rheumatol Int       Date:  2021-05-02       Impact factor: 3.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.